CREB1 and colorectal cancer: Diosgenin inhibits aerobic glycolysis in colorectal cancer cells by regulating glucose transporters (GLUT3 and GLUT4) and inhibiting CREB phosphorylation through the cAMP/PKA/CREB pathway, leading to apoptosis [87].